Overview

Endothelial Cell Activation and Total Pulmonary Resistance in PAH

Status:
NOT_YET_RECRUITING
Trial end date:
2026-10-31
Target enrollment:
Participant gender:
Summary
To determine whether changes in endothelial cell dysfunction are associated with changes in total pulmonary resistance in patients with pulmonary arterial hypertension
Phase:
NA
Details
Lead Sponsor:
Imperial College London
Treatments:
N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide